Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
16. November 2020 12:48 ET
|
Processa Pharmaceuticals Inc.
HANOVER, MD., Nov. 16, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing...
Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update
12. November 2020 17:02 ET
|
Processa Pharmaceuticals Inc.
HANOVER, MD., Nov. 12, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (“Processa” or the “Company”), a clinical-stage biopharmaceutical company focused on...
Processa Pharmaceuticals Schedules Conference Call to Discuss Third Quarter Results and Provide Drug Development Update on Nov. 12 at 5:30 p.m. ET
03. November 2020 09:20 ET
|
Processa Pharmaceuticals Inc.
HANOVER, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing...